Combination Monoclonal Antibody Therapy Significantly Reduced Hospitalization And Death Versus Placebo In Patients With COVID-19 At High Risk Of Progressing To Severe Disease, Interim Data Indicate

MedPage Today (8/25, Walker) reports, “A combination monoclonal antibody therapy significantly reduced hospitalization and death versus placebo in” patients with COVID-19 “at high risk of progressing to severe disease, according to interim data from the p...